Talecris Biotherapeutics, Inc.
Company Overview:
Talecris Biotherapeutics, Inc. was a biopharmaceutical company focused on the development and commercialization of plasma-derived therapies. The company specialized in the treatment of various bleeding disorders and immune deficiencies. Prior to its acquisition, Talecris held a significant position in the plasma protein therapeutics market, offering a range of products to healthcare providers globally. Their products were primarily derived from human plasma through a rigorous processing and purification process.
Continue…Key Products & Therapeutic Areas:
While a comprehensive list of all their past products isn't readily available through general online searches, Talecris's portfolio centered around plasma-derived therapies, addressing the needs of patients with:
- Hemophilia: This was a major focus area, likely encompassing products such as clotting factor concentrates.
- Immune Deficiencies: The company likely offered immunoglobulin products to support patients with compromised immune systems.
- Other Bleeding Disorders: Their portfolio likely extended to address other rare bleeding disorders beyond hemophilia.
Acquisition & Current Status:
Talecris Biotherapeutics, Inc. is no longer an independent entity. It was acquired by Grifols, a global healthcare company, in 2011. Following the acquisition, Talecris's operations and product lines were integrated into Grifols' existing structure. Therefore, information regarding specific products and operations would now be found under the Grifols umbrella.
Former Location & Operations:
While the precise location of their headquarters and primary operational facilities before acquisition is not easily accessible through typical online searches, it's highly probable they were located in the United States, given the nature of their business and the prominence of the US biopharmaceutical industry.
Post-Acquisition Information:
To find detailed information on the products and operations once handled by Talecris Biotherapeutics, Inc., one should consult Grifols' corporate website and documentation. This would provide information on the current status of any products that were previously under the Talecris brand and how they have been integrated into Grifols' overall business.
